Breccia, M., and G. Alimena. “SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs”. Mediterranean Journal of Hematology and Infectious Diseases, Vol. 6, no. 1, Jan. 2014, p. e2014003, doi:10.4084/mjhid.2014.003.